Mark K. Bennett

Researcher Next ID · RN-008615

Researcher · Biochemistry, Genetics and Molecular Biology

Wellington, New Zealand

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Ubiquitin and proteasome pathways

Cancer, Hypoxia, and Metabolism

Cancer Research and Treatments

Cellular transport and secretion

Multiple Myeloma Research and Treatments

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Molecular Cancer Therapeutics · 2014 · https://doi.org/10.1158/1535-7163.mct-13-0870
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma
Blood · 2007 · https://doi.org/10.1182/blood-2007-01-065888
The natural history of nonalcoholic fatty liver: A follow-up study
Hepatology · 1995 · https://doi.org/10.1002/hep.1840220616
A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion
Cell · 1993 · https://doi.org/10.1016/0092-8674(93)90376-2
Syntaxin: A Synaptic Protein Implicated in Docking of Synaptic Vesicles at Presynaptic Active Zones
Science · 1992 · https://doi.org/10.1126/science.1321498

No projects listed.